|
Top Athletes Find Success Using Wellness International Network's Products
Pharmaceutical
Top Athletes Find Success Using Wellness International Network's Products
With more than 18 years of success stories; more and more professional and elite athletes are using Wellness International Network's products for an edge in their sport.
15:07 Jul 30, 2010
Competition Bureau Requires Divestitures in Teva/Ratiopharm Merger
The Bureau concluded that the merger would likely lead to a substantial lessening of competition in the supply of acetaminophen oxycodone tablets and morphine sulfate sustained-release tablets in Canada.
14:17 Jul 30, 2010
Generex Announces AGM Results
Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.
13:38 Jul 30, 2010
Dynavax Reports 2010 Second Quarter Financial Results
DYNAVAX TECHNOLOGIES CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS ( In thousands, except per share amounts) ( Unaudited) Three Months Ended Six Months Ended June 30, June 30, 2010 2009 2010 2009 Revenues: Collaboration revenue $ 1,341
13:37 Jul 30, 2010
Save the Children Mobilizing to Help Families Affected by Pakistan Flooding
Save the Children, which has worked in Pakistan for more than 25 years, is preparing to distribute plastic sheeting for shelters and other household supplies and hygiene kits to 1,000 families in the next 48 hours.
13:37 Jul 30, 2010
MethylGene Reports Second Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
STATEMENTS OF CASH FLOWS ( In thousands of Canadian dollars) Three-month period Six-month period ended June 30, ended June 30, 2010 2009 2010 2009 $ $ $ $ OPERATING ACTIVITIES Net loss for the period ( 3,414) ( 6,917) ( 7,936) ( 13,028) Ite
13:17 Jul 30, 2010
MethylGene Reports Second Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
STATEMENTS OF CASH FLOWS ( In thousands of Canadian dollars) Three-month period Six-month period ended June 30, ended June 30, 2010 2009 2010 2009 $ $ $ $ OPERATING ACTIVITIES Net loss for the period ( 3,414) ( 6,917) ( 7,936) ( 13,028) Ite
13:17 Jul 30, 2010
Laxai Pharma Ltd. and UTA Capital LLC Agree to Extend Term of $1.44 Million Term Loan and Reduce Its
Laxai Pharma Ltd. Ram Ajjarapu, Executive Chairman ( 813)- 428-3500
12:26 Jul 30, 2010
Laxai Pharma Ltd. and UTA Capital LLC Agree to Extend Term of $1.44 Million Term Loan and Reduce Its
Laxai Pharma Ltd. Ram Ajjarapu, Executive Chairman ( 813)- 428-3500
12:26 Jul 30, 2010
Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders of Class A
KSF is a law firm focused on securities class action litigation with offices in Louisiana and New York.
11:17 Jul 30, 2010
LandStar, Inc. (LDSR) Reports Second Quarter Financials
In addition to those discussed in LandStar Inc.', s press releases, public filings, and statements by LandStar Inc.', s management, including, but not limited to, LandStar Inc.', s estimate of the sufficiency of its existing capital resourc
09:37 Jul 30, 2010
Growth in IVD Testing Despite Economic Jitters, Says Report
The report, " Worldwide Market for In Vitro Diagnostic Tests, 7th Edition", has more information on segment market sizes, forecasts, company analyses, and test product development.
09:17 Jul 30, 2010
Axia Group (AGIJ) Purchases Collagenna Skin Care Products From Hard to Treat Diseases (HTDS)
In addition to those discussed in Axia Group Inc.', s press releases, public filings, and statements by Axia Group Inc.', s management, including, but not limited to, Axia Group Inc.', s estimate of the sufficiency of its existing capital r
09:07 Jul 30, 2010
Hard to Treat Diseases (HTDS) Sells Collagenna to Axia Group Inc. (AGIJ)
In addition to those discussed in Hard to Treat Diseases, Inc.', s press releases, public filings, and statements by Hard to Treat Diseases, Inc.', s management, including, but not limited to, Hard to Treat Diseases, Inc.', s estimate of th
09:07 Jul 30, 2010
Axia Group (AGIJ) Purchases Collagenna Skin Care Products From Hard to Treat Diseases (HTDS)
In addition to those discussed in Axia Group Inc.', s press releases, public filings, and statements by Axia Group Inc.', s management, including, but not limited to, Axia Group Inc.', s estimate of the sufficiency of its existing capital r
09:07 Jul 30, 2010
...
News Copyright © 2006 Interest!ALERT
|
|
|